Nifty
Sensex
:
:
14238.90
48347.59
-133.00 (-0.93%)
-530.95 (-1.09%)

Pharmaceuticals & Drugs

Rating :
72/99  (View)

BSE: 524774 | NSE: Not Listed

1206.50
20.20 (1.70%)
25-Jan-2021 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1194.00
  •  1245.60
  •  1179.50
  •  1186.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  13025
  •  157.15
  •  1374.95
  •  220.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 745.38
  • 28.53
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 770.45
  • 0.14%
  • 6.07

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.81%
  • 1.31%
  • 22.30%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.58%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.71
  • 9.59
  • 10.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.69
  • -0.98
  • -0.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.97
  • -1.44
  • -5.67

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 30.72

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.65
  • 2.08
  • 4.80

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.23
  • 7.03
  • 16.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
68.34
37.21
83.66%
42.37
40.70
4.10%
35.44
43.46
-18.45%
37.42
34.47
8.56%
Expenses
47.94
32.91
45.67%
28.92
32.25
-10.33%
33.14
32.78
1.10%
34.19
27.10
26.16%
EBITDA
20.40
4.30
374.42%
13.45
8.45
59.17%
2.30
10.68
-78.46%
3.23
7.37
-56.17%
EBIDTM
29.85%
11.56%
31.74%
20.76%
6.49%
24.57%
8.64%
21.39%
Other Income
2.76
1.06
160.38%
2.18
1.35
61.48%
0.83
1.25
-33.60%
1.19
0.73
63.01%
Interest
0.54
0.66
-18.18%
0.60
0.48
25.00%
0.60
0.53
13.21%
0.64
0.64
0.00%
Depreciation
2.05
1.97
4.06%
2.10
1.87
12.30%
2.21
1.61
37.27%
2.06
1.62
27.16%
PBT
20.57
2.74
650.73%
12.93
7.45
73.56%
0.32
9.78
-96.73%
1.72
5.84
-70.55%
Tax
4.76
0.39
1,120.51%
3.54
2.25
57.33%
0.51
2.98
-82.89%
0.59
1.77
-66.67%
PAT
15.81
2.35
572.77%
9.39
5.20
80.58%
-0.19
6.81
-
1.13
4.07
-72.24%
PATM
23.13%
6.30%
22.16%
12.77%
-0.53%
15.66%
3.02%
11.81%
EPS
25.59
3.80
573.42%
15.19
8.41
80.62%
-0.32
11.02
-
1.82
6.59
-72.38%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Net Sales
183.57
151.69
153.17
Net Sales Growth
17.79%
-0.97%
 
Cost Of Goods Sold
78.85
64.36
62.63
Gross Profit
104.72
87.32
90.54
GP Margin
57.05%
57.56%
59.11%
Total Expenditure
144.19
131.93
120.88
Power & Fuel Cost
-
10.30
9.02
% Of Sales
-
6.79%
5.89%
Employee Cost
-
24.04
21.16
% Of Sales
-
15.85%
13.81%
Manufacturing Exp.
-
17.22
13.21
% Of Sales
-
11.35%
8.62%
General & Admin Exp.
-
6.11
5.33
% Of Sales
-
4.03%
3.48%
Selling & Distn. Exp.
-
4.64
4.58
% Of Sales
-
3.06%
2.99%
Miscellaneous Exp.
-
5.25
4.95
% Of Sales
-
3.46%
3.23%
EBITDA
39.38
19.76
32.29
EBITDA Margin
21.45%
13.03%
21.08%
Other Income
6.96
3.05
4.12
Interest
2.38
2.63
2.55
Depreciation
8.42
8.11
6.30
PBT
35.54
12.07
27.57
Tax
9.40
3.74
7.44
Tax Rate
26.45%
30.99%
26.99%
PAT
26.14
8.34
20.13
PAT before Minority Interest
26.14
8.34
20.13
Minority Interest
0.00
0.00
0.00
PAT Margin
14.24%
5.50%
13.14%
PAT Growth
41.83%
-58.57%
 
Unadjusted EPS
42.16
13.45
32.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Shareholder's Funds
98.96
92.12
Share Capital
3.09
3.09
Total Reserves
95.87
89.03
Non-Current Liabilities
11.62
11.90
Secured Loans
8.32
8.01
Unsecured Loans
0.00
0.00
Long Term Provisions
2.11
1.40
Current Liabilities
48.71
45.18
Trade Payables
20.83
16.12
Other Current Liabilities
6.34
5.61
Short Term Borrowings
14.60
15.31
Short Term Provisions
6.93
8.15
Total Liabilities
159.29
149.20
Net Block
67.74
60.94
Gross Block
91.81
74.07
Accumulated Depreciation
24.07
13.13
Non Current Assets
72.76
62.80
Capital Work in Progress
0.00
0.00
Non Current Investment
0.00
0.00
Long Term Loans & Adv.
5.00
1.81
Other Non Current Assets
0.01
0.04
Current Assets
86.53
86.41
Current Investments
10.65
8.69
Inventories
27.90
18.61
Sundry Debtors
26.19
33.12
Cash & Bank
3.16
3.14
Other Current Assets
18.63
7.24
Short Term Loans & Adv.
12.17
15.61
Net Current Assets
37.82
41.23
Total Assets
159.29
149.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Cash From Operating Activity
20.46
8.85
PBT
12.07
27.57
Adjustment
12.16
7.87
Changes in Working Capital
-0.03
-19.15
Cash after chg. in Working capital
24.20
16.29
Interest Paid
0.00
0.00
Tax Paid
-3.74
-7.44
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-20.85
-9.54
Net Fixed Assets
-7.18
Net Investments
-5.69
Others
-7.98
Cash from Financing Activity
0.00
0.00
Net Cash Inflow / Outflow
-0.39
-0.70
Opening Cash & Equivalents
0.79
1.49
Closing Cash & Equivalent
0.40
0.79

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Book Value (Rs.)
160.18
149.11
ROA
5.40%
13.49%
ROE
8.72%
21.85%
ROCE
11.93%
25.25%
Fixed Asset Turnover
1.83
2.07
Receivable days
71.37
78.93
Inventory Days
55.95
44.35
Payable days
47.96
48.15
Cash Conversion Cycle
79.36
75.13
Total Debt/Equity
0.29
0.29
Interest Cover
5.60
11.82

News Update


  • NGL Fine-Chem - Quarterly Results
    6th Nov 2020, 19:13 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.